Recent Activity

Loading...

ABSI

Absci Corporation · NASDAQ

Performance

-10.21%

1W

-14.22%

1M

-13.41%

3M

+232.01%

6M

+9.88%

YTD

+282.99%

1Y

Profile

Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Investment Analysis Report: ABSI

Overview

ABSI operates in the Commercial Services sector, specifically in Miscellaneous Commercial Services. The company has a market capitalization of $495.36 million. In this report, we will conduct a detailed analysis of ABSI's financial health, valuation, earnings and revenue growth, profitability, operating ...

See more ...

Technical Analysis of ABSI 2024-05-10

Overview:

In the last 5 trading days, ABSI stock has shown mixed price movements with fluctuations in volume. The technical indicators across trend, momentum, volatility, and volume categories provide insights into the stock's potential future price movements. Let's analyze each category in detail to determine the possible next few days' stock p...

See more ...

Recent News & Updates